Literature DB >> 8841560

Functional structure of the promoter region of the human thymidylate synthase gene and nuclear factors that regulate the expression of the gene.

N Horie1, K Takeishi.   

Abstract

To identify the essential motifs of the promoter of the human thymidylate synthase (hTS) gene, we constructed a set of deletion mutants that covers the region from -441 to +28 of the hTS gene. (The nucleotide positions are numbered from the first position of the initiation codon of the hTS gene.) From the results of chloramphenicol acetyltransferase (CAT) assay of these mutants, two positive elements for the promoter activity were identified: one contains CACCC box (CCACACCC) that is found in the SV40 enhancer motif and the other contains the sequence that is homologous to the Sp1 binding site in the mouse TS gene. Furthermore, two negative regulatory sequences were identified between the two positive elements and upstream from the CACCC box. Cassette mutations were introduced into these motifs and the function of the motifs was confirmed. From the results of gel mobility shift analysis, we found that three nucleoprotein complexes were formed in the promoter region of the hTS gene. The formation of one of the complexes was competed by the DNA fragment bearing the GC box. The gel mobility shift analyses using the DNA fragments with cassette mutations revealed that the complex was formed on the Sp1 binding site of the hTS gene and the formation of the complex correlated with the promoter activity of the fragments with cassette mutations measured by the CAT assay.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8841560

Source DB:  PubMed          Journal:  Nucleic Acids Symp Ser        ISSN: 0261-3166


  6 in total

1.  Beyond Thymidylate Synthase and Dihydrofolate Reductase: Impact of Non-coding microRNAs in Anticancer Chemoresistance.

Authors:  Jingfang Ju
Journal:  Curr Enzym Inhib       Date:  2012-09-01

2.  Predictive and prognostic markers in colorectal cancer.

Authors:  Peter M Wilson; Robert D Ladner; Heinz-Josef Lenz
Journal:  Gastrointest Cancer Res       Date:  2007-11

3.  Novel opportunities for thymidylate metabolism as a therapeutic target.

Authors:  Peter M Wilson; William Fazzone; Melissa J LaBonte; Jinxia Deng; Nouri Neamati; Robert D Ladner
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

Review 4.  Impact of pharmacogenomics on clinical practice in oncology.

Authors:  Sharon Marsh
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

5.  Severe hypoxia induces complete antifolate resistance in carcinoma cells due to cell cycle arrest.

Authors:  S Raz; D Sheban; N Gonen; M Stark; B Berman; Y G Assaraf
Journal:  Cell Death Dis       Date:  2014-02-20       Impact factor: 8.469

Review 6.  A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.

Authors:  J M Findlay; M R Middleton; I Tomlinson
Journal:  Ann Oncol       Date:  2014-09-11       Impact factor: 32.976

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.